M J Zibaeenezhad1, P Farhadi2, A Attar3, A Mosleh1,2, F Amirmoezi1, A Azimi2. 1. Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. 2. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran. 3. Cardiovascular Research Center, TAHA Clinical Trial Group, Mohammad Rasool Allah Research Tower, Shiraz University of Medical Sciences, Shiraz, Iran.
Abstract
BACKGROUND: The role of herbal medicine is now well documented in preventing and controlling diabetes mellitus. The main aim of this study was to evaluate the effects of walnut oil consumption on lipid profiles of hyperlipidemic patients with type 2 diabetes. METHODS: In a randomized, double-blind, placebo-controlled clinical trial, 100 hyperlipidemic type 2 diabetic patients aged 35-75 years were assigned to receive 15 cc Persian walnut oil or placebo every day for 90 days. The primary outcomes were the lipid profiles. RESULTS: Consumption of walnut oil by type 2 hyperlipidemic diabetic patients resulted in a significant decrease in total cholesterol levels (treatment difference (TD)=-30.04, P<0.001), triglyceride (TG) level (TD=-15.04, P=0.021), low-density lipoprotein (LDL) level (TD=-30.44, P<0.001) and total cholesterol to high-density lipoprotein (HDL) ratio (TD=-0.72, P<0.001) compared to the control group. There was a trend toward increasing HDL level with consumption of walnut oil (TD=2.28, P=0.06). Frequency of patients reaching a LDL level below 100 was higher in the case group (20 vs 0%). CONCLUSIONS: Addition of walnut oil in the daily diet of type 2 diabetic patients improves lipid profiles. Thus, it may be associated with a coronary artery disease risk factor modulation. Also, walnut oil may serve as a helpful natural remedy for hyperlipidemic patients with type 2 diabetes.
RCT Entities:
BACKGROUND: The role of herbal medicine is now well documented in preventing and controlling diabetes mellitus. The main aim of this study was to evaluate the effects of walnut oil consumption on lipid profiles of hyperlipidemic patients with type 2 diabetes. METHODS: In a randomized, double-blind, placebo-controlled clinical trial, 100 hyperlipidemic type 2 diabeticpatients aged 35-75 years were assigned to receive 15 cc Persian walnut oil or placebo every day for 90 days. The primary outcomes were the lipid profiles. RESULTS: Consumption of walnut oil by type 2 hyperlipidemic diabeticpatients resulted in a significant decrease in total cholesterol levels (treatment difference (TD)=-30.04, P<0.001), triglyceride (TG) level (TD=-15.04, P=0.021), low-density lipoprotein (LDL) level (TD=-30.44, P<0.001) and total cholesterol to high-density lipoprotein (HDL) ratio (TD=-0.72, P<0.001) compared to the control group. There was a trend toward increasing HDL level with consumption of walnut oil (TD=2.28, P=0.06). Frequency of patients reaching a LDL level below 100 was higher in the case group (20 vs 0%). CONCLUSIONS: Addition of walnut oil in the daily diet of type 2 diabeticpatients improves lipid profiles. Thus, it may be associated with a coronary artery disease risk factor modulation. Also, walnut oil may serve as a helpful natural remedy for hyperlipidemic patients with type 2 diabetes.
Authors: John M Morgan; Kirsten Horton; Dana Reese; Christina Carey; Kalen Walker; David M Capuzzi Journal: Int J Vitam Nutr Res Date: 2002-10 Impact factor: 1.784
Authors: Claire E Berryman; Jessica A Grieger; Sheila G West; Chung-Yen O Chen; Jeffrey B Blumberg; George H Rothblat; Sandhya Sankaranarayanan; Penny M Kris-Etherton Journal: J Nutr Date: 2013-04-24 Impact factor: 4.798
Authors: Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone Journal: J Am Coll Cardiol Date: 2004-08-04 Impact factor: 24.094
Authors: L C Tapsell; M J Batterham; G Teuss; S-Y Tan; S Dalton; C J Quick; L J Gillen; K E Charlton Journal: Eur J Clin Nutr Date: 2009-04-08 Impact factor: 4.016
Authors: J N Din; S M Aftab; A W Jubb; F H Carnegy; K Lyall; J Sarma; D E Newby; A D Flapan Journal: Eur J Clin Nutr Date: 2010-11-03 Impact factor: 4.016
Authors: Kamil Borkowski; Sun J Yim; Roberta R Holt; Robert M Hackman; Carl L Keen; John W Newman; Gregory C Shearer Journal: J Nutr Biochem Date: 2019-03-28 Impact factor: 6.048
Authors: Kaushik Chattopadhyay; Haiquan Wang; Jaspreet Kaur; Gamze Nalbant; Abdullah Almaqhawi; Burak Kundakci; Jeemon Panniyammakal; Michael Heinrich; Sarah Anne Lewis; Sheila Margaret Greenfield; Nikhil Tandon; Tuhin Kanti Biswas; Sanjay Kinra; Jo Leonardi-Bee Journal: Front Pharmacol Date: 2022-06-08 Impact factor: 5.988
Authors: Nicola J A Scott; Leigh J Ellmers; Anna P Pilbrow; Lotte Thomsen; Arthur Mark Richards; Chris M Frampton; Vicky A Cameron Journal: Nutrients Date: 2017-07-07 Impact factor: 5.717